ID: ALA2371992

Max Phase: Preclinical

Molecular Formula: C183H262N38O29

Molecular Weight: 3458.35

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N1Cc2ccccc2C[C@H]1C(=O)N1CC2CCCCC2[C@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N1Cc2ccccc2C[C@H]1C(=O)N1CC2CCCCC2[C@H]1C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)N1CC2CCCCC2[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1Cc2ccccc2C[C@H]1C(=O)N1CC2CCCCC2[C@H]1C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)N1CC2CCCCC2[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1Cc2ccccc2C[C@H]1C(=O)N1CC2CCCCC2[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O

Standard InChI:  InChI=1S/C183H262N38O29/c1-106(2)77-139(206-153(227)87-194-163(231)134(65-31-35-71-184)201-148(222)86-189)174(242)213-97-118-50-16-10-44-112(118)83-145(213)180(248)221-105-126-58-24-28-62-130(126)159(221)168(236)198-91-152(226)205-138(69-39-75-188)173(241)212-96-117-49-15-9-43-111(117)82-144(212)179(247)218-102-123-55-21-30-64-132(123)161(218)170(238)200-93-155(229)208-141(79-108(5)6)176(244)215-99-120-52-18-12-46-114(120)85-147(215)182(250)220-104-125-57-23-27-61-129(125)158(220)167(235)197-90-151(225)204-137(68-34-38-74-187)172(240)211-95-116-48-14-8-42-110(116)81-143(211)178(246)217-101-122-54-20-29-63-131(122)160(217)169(237)199-92-154(228)207-140(78-107(3)4)175(243)214-98-119-51-17-11-45-113(119)84-146(214)181(249)219-103-124-56-22-26-60-128(124)157(219)166(234)196-89-150(224)203-136(67-33-37-73-186)171(239)210-94-115-47-13-7-41-109(115)80-142(210)177(245)216-100-121-53-19-25-59-127(121)156(216)165(233)195-88-149(223)202-135(66-32-36-72-185)164(232)209-133(162(190)230)70-40-76-193-183(191)192/h7-18,41-52,106-108,121-147,156-161H,19-40,53-105,184-189H2,1-6H3,(H2,190,230)(H,194,231)(H,195,233)(H,196,234)(H,197,235)(H,198,236)(H,199,237)(H,200,238)(H,201,222)(H,202,223)(H,203,224)(H,204,225)(H,205,226)(H,206,227)(H,207,228)(H,208,229)(H,209,232)(H4,191,192,193)/t121?,122?,123?,124?,125?,126?,127?,128?,129?,130?,131?,132?,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,156-,157-,158-,159-,160-,161-/m0/s1

Standard InChI Key:  CKRUXJGERQZLPU-OOBIBZRBSA-N

Associated Targets(non-human)

Mycobacterium 258 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Bacillus subtilis 32866 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Salmonella typhimurium 15756 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 3458.35Molecular Weight (Monoisotopic): 3456.0195AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Hicks RP, Bhonsle JB, Venugopal D, Koser BW, Magill AJ..  (2007)  De novo design of selective antibiotic peptides by incorporation of unnatural amino acids.,  50  (13): [PMID:17547385] [10.1021/jm061489v]

Source